1. Home
  2. BWG vs LFCR Comparison

BWG vs LFCR Comparison

Compare BWG & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWG
  • LFCR
  • Stock Information
  • Founded
  • BWG 2012
  • LFCR 1986
  • Country
  • BWG United States
  • LFCR United States
  • Employees
  • BWG N/A
  • LFCR N/A
  • Industry
  • BWG Finance/Investors Services
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWG Finance
  • LFCR Health Care
  • Exchange
  • BWG Nasdaq
  • LFCR Nasdaq
  • Market Cap
  • BWG 142.1M
  • LFCR 164.3M
  • IPO Year
  • BWG N/A
  • LFCR N/A
  • Fundamental
  • Price
  • BWG $8.15
  • LFCR $7.17
  • Analyst Decision
  • BWG
  • LFCR Buy
  • Analyst Count
  • BWG 0
  • LFCR 2
  • Target Price
  • BWG N/A
  • LFCR $10.00
  • AVG Volume (30 Days)
  • BWG 53.8K
  • LFCR 209.5K
  • Earning Date
  • BWG 01-01-0001
  • LFCR 01-02-2025
  • Dividend Yield
  • BWG 11.37%
  • LFCR N/A
  • EPS Growth
  • BWG N/A
  • LFCR N/A
  • EPS
  • BWG N/A
  • LFCR 0.17
  • Revenue
  • BWG N/A
  • LFCR $128,443,999.00
  • Revenue This Year
  • BWG N/A
  • LFCR $2.23
  • Revenue Next Year
  • BWG N/A
  • LFCR $8.40
  • P/E Ratio
  • BWG N/A
  • LFCR $50.46
  • Revenue Growth
  • BWG N/A
  • LFCR 23.42
  • 52 Week Low
  • BWG $6.86
  • LFCR $3.68
  • 52 Week High
  • BWG $8.65
  • LFCR $8.90
  • Technical
  • Relative Strength Index (RSI)
  • BWG 32.61
  • LFCR 48.90
  • Support Level
  • BWG $8.06
  • LFCR $6.85
  • Resistance Level
  • BWG $8.53
  • LFCR $7.88
  • Average True Range (ATR)
  • BWG 0.10
  • LFCR 0.42
  • MACD
  • BWG -0.03
  • LFCR -0.11
  • Stochastic Oscillator
  • BWG 18.75
  • LFCR 18.93

About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.

BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in global fixed-income securities.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Share on Social Networks: